🔗 Share this article

Chancellor Reeves has revealed she is planning "focused action to tackle household expense pressures" in the forthcoming Budget.

Speaking to media outlets, she emphasized that curbing inflation is a shared task of both the government and the Bank of England.

The United Kingdom's price growth is expected to be the highest among the Group of Seven advanced economies this year and next.

Possible Energy Bill Interventions

It is understood the administration could intervene to lower utility costs, for instance by slashing the current 5% rate of value-added tax applied on energy supplies.

An additional option is to cut some of the regulatory levies currently included in bills.

Fiscal Constraints and Analyst Expectations

The government will obtain the latest assessment from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will clarify how much room there is for such measures.

The view from most analysts is that Reeves will have to introduce higher taxes or expenditure reductions in order to meet her voluntary fiscal targets.

Earlier on Thursday, calculations indicated there was a £22bn shortfall for the chancellor to fill, which is at the lower end of projections.

"It is a collective responsibility between the central bank and the administration to further reduce some of the causes of inflation," the Chancellor stated to the BBC in Washington, at the yearly gatherings of the International Monetary Fund and World Bank.

Tax Pledges and Global Issues

While much of the attention has been on likely tax increases, the Treasury chief said the latest information from the fiscal watchdog had not altered her commitment to campaign commitments not to increase tax levels on income tax, sales tax or social security contributions.

She attributed an "uncertain global environment" with rising international and commercial tensions for the Budget revenue measures, probably to be targeted on those "with the broadest shoulders."

Global Economic Tensions

Referring to concerns about the United Kingdom's economic relations with the Asian nation she said: "The UK's security interests always are paramount."

Last week's declaration by Chinese authorities to strengthen export controls on rare earths and other resources that are key for high-technology manufacturing led American leader the US President to threaten an further 100% tariff on goods from China, increasing the possibility of an full-scale commercial conflict between the two global powers.

The American finance chief called the Chinese move "commercial pressure" and "a global supply chain power grab."

Inquired about considering the US offer to participate in its battle with China, the Chancellor said she was "very concerned" by Chinese measures and urged the Chinese government "to avoid restrictions and restrict access."

She said the move was "harmful for the global economy and causes additional headwinds."

"I believe there are areas where we need to confront Chinese policies, but there are also valuable opportunities to export to Chinese markets, including banking sector and other areas of the economy. We've got to maintain that equilibrium appropriate."

The Treasury chief also affirmed she was working with other major economies "on our own critical minerals plan, so that we are less reliant."

NHS Drug Costs and Funding

Reeves also recognized that the price the National Health Service spends on pharmaceuticals could increase as a consequence of current negotiations with the Trump administration and its drugs companies, in return for reduced taxes and capital.

A number of the biggest global drug companies have said in recent statements that they are either pausing or canceling projects in the UK, with several blaming the modest returns they are getting.

Last month, the Science Minister said the cost the health service pays for drugs would need to go up to halt companies and drug research funding leaving the United Kingdom.

The Chancellor told the BBC: "It has been observed because of the payment system, that clinical trials, recent pharmaceuticals have not been offered in the UK in the way that they are in other continental states."

"We want to make sure that individuals getting care from the National Health Service are can receive the best essential drugs in the globe. And so we are looking at these issues, and... seeking to secure additional funding into Britain."